Pharmaceutical giant Pfizer announced this week that it has started an early stage clinical trial to test an oral antiviral drug for Covid-19. The experimental oral antiviral drug is in a phase one trial called PF-07321332 which is being conducted in the United States. It is the first protease inhibitor taken by mouth for Covid-19 … Continue reading “Pfizer Begins Early Stage Clinical Trial for a Covid-19 Oral Antiviral Drug”
